Vol.
40
No.
10
December 07, 2017Dec 07, 2017
Trending Stories
- TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - In her own words: Rathmell reflects on her priorities and values—and encourages everyone to do the same
- Steven Libutti tells us about building a $900 million cancer hospital for Rutgers RWJBarnabas Health
- White House preliminary budget document provides no funds for highly impactful CDC cancer registries program
- Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI
